Research Article
YQFM Alleviates Side Effects Caused by Dasatinib through the ROCK/MLC Pathway in Mice
Figure 3
Effect of YQFM on the expression of connexin in mice with Dasatinib. YQFM (0.336, 0.672, 1.342 g/kg, i.p.) was injected intraperitoneally 1 h before being administered with dasatinib (70 mg/kg for 3 d, i.p.). (a–c) Representative western blots and the quantitative analysis of the ratio of ZO-1, occludin, and VE-cadherin. Data are expressed as the mean ± SD, n = 3. vs. control mice; vs. control mice; vs. control mice; vs. model group; vs. model mice; vs. model group.
(a) |
(b) |
(c) |